Effects of Glycemic Variability on Regulatory T Cells in Patients with Type 2 Diabetes and Kidney Disease

被引:1
|
作者
Gu, Qing-Wei [1 ]
Sun, Qi [1 ]
Wang, Jie [1 ]
Gu, Wen-Sha [1 ]
Wang, Wei [1 ]
Mao, Xiao-Ming [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Endocrinol, 68 ChangLe St, Nanjing 210006, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
type 2 diabetes mellitus; diabetic kidney disease; glycemic variability; regulatory T cells; inflammatory cytokines; INFLAMMATION; NEPHROPATHY; MECHANISMS; PATHOGENESIS; RISK;
D O I
10.2147/DMSO.S413407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the pathogenesis of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM), we evaluated the effects of short-term glycemic variability (GV) on the profile of T cell subpopulations.Methods: A total of 47 T2DM patients with normoalbuminuria, 47 microalbuminuria, and 49 macroalbuminuria were enrolled. The continuous glucose monitoring (CGM) determined the GV of enrolled patients. Flow cytometry was used to determine the proportion of T cell subpopulations.Results: The frequency of T helper (Th) 17 and Th1 cells significantly increased while regulatory T cells (Tregs) significantly decreased in the macroalbuminuria group compared to normoalbuminuria and microalbuminuria groups (P < 0.01). The suppressive function of Tregs was significantly lower in the macroalbuminuria group than the normoalbuminuria group (P < 0.05). Compared with the normoalbuminuria group, the mean amplitude of glucose excursions (MAGE) of the macroalbuminuria group was significantly higher (P<0.05). Furthermore, there were negative associations between the proportion of Tregs and MAGE.Conclusions: Increased GV could decrease the proportion of Tregs and may impair their function. This may lead to increases in Th1 and Th17 cells, and some inflammatory cytokines, which might contribute to the development and progression of DKD in T2DM.
引用
收藏
页码:2365 / 2375
页数:11
相关论文
共 50 条
  • [31] Glycemic Variability but Not Glycemic Exposure Predicts Lower Heart Rate Variability in Patients With Type 1 Diabetes
    Jaiswal, Mamta
    Plunkett, Cynthia
    Nelson, Patrick
    Henderson, James
    Comment, Nicholas
    Pop-Busui, Rodica
    DIABETES, 2013, 62 : A45 - A45
  • [32] Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus
    Harada, Koji
    Sumida, Koichi
    Yamaguchi, Yukinari
    Akai, Yasuhiro
    CLINICAL NEPHROLOGY, 2014, 82 (02) : 107 - 114
  • [33] The Impact of Glucose Variability on Achievement of Glycemic Control and Risk of Hypoglycemia in Patients with Type 2 Diabetes (T2D)
    Umpierrez, Guillermo E.
    Digenio, Andres
    Zhou, Rong
    Inzucchi, Silvio
    DIABETES, 2011, 60 : A310 - A311
  • [34] Type 1 diabetes and T regulatory cells
    ElEssawy, Basset
    Li, Xian C.
    PHARMACOLOGICAL RESEARCH, 2015, 98 : 22 - 30
  • [35] Regulatory T cells and type 1 diabetes
    Homann, D
    von Herrath, M
    CLINICAL IMMUNOLOGY, 2004, 112 (03) : 202 - 209
  • [36] Regulatory T cells and type 1 diabetes
    Bisikirska B.C.
    Herold K.C.
    Current Diabetes Reports, 2005, 5 (2) : 104 - 109
  • [37] Regulatory T cells in kidney disease and transplantation
    Hu, Min
    Wang, Yuan Min
    Wang, Yiping
    Zhang, Geoff Y.
    Zheng, Guoping
    Yi, Shounan
    O'Connell, Philip J.
    Harris, David C. H.
    Alexander, Stephen I.
    KIDNEY INTERNATIONAL, 2016, 90 (03) : 502 - 514
  • [38] Relationship between glycemic variability and cognitive function in lacune patients with type 2 diabetes
    Meng, Qi-Zhe
    Wang, Yang
    Li, Bing
    Xi, Zhi
    Wang, Ming
    Xiu, Jia-Qi
    Yang, Xiao-Peng
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (05) : 1019 - 1030
  • [39] Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function
    Kramer, Caroline K.
    Choi, Haysook
    Zinman, Bernard
    Retnakaran, Ravi
    DIABETES CARE, 2014, 37 (04) : 1116 - 1123
  • [40] GLYCEMIC VARIABILITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL IMPLICATIONS AND PHARMACOLOGICAL CONSIDERATIONS
    Howsawi, Alanood
    Alem, Manal
    JOURNAL OF HYPERTENSION, 2023, 41 : E151 - E151